Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation

BACKGROUND: Early in the pandemic, there were no evidence-based treatments for SARS-CoV-2, creating an urgent need to identify effective therapeutics. However, public participation in medical research is low; trial enrollment in the US is typically 10–20%. Thus, the aim of this study was to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Dassum, Samira Reyes, Ferguson, Ryan, Woods, Patricia, Flynn, Maura, Visnaw, Karen, Holmberg, Erika, Schiller, Sara, Shannon, Colleen, Brophy, Mary, Monach, Paul, Leatherman, Sarah, Branch-Elliman, Westyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827740/
https://www.ncbi.nlm.nih.gov/pubmed/36632925
http://dx.doi.org/10.1016/j.cct.2023.107082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827740/
https://www.ncbi.nlm.nih.gov/pubmed/36632925
http://dx.doi.org/10.1016/j.cct.2023.107082

Ejemplares similares